机构：[1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China,[2]South Sichuan Institute of Translational Medicine, Luzhou, China,[3]Neijiang Health and Health Vocational College, Neijiang, China,[4]Department of Oncology and Hematology, Hospital (T.C.M.) Affiliated to Southwest Medical University, Luzhou, China,[5]Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China
This work was supported by the National Natural Science
Foundation of China (Grant nos. 81602166 and 81672444) and
Sichuan Science and Technology Plan Project (2018JY0079).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类|3 区生物学
小类|4 区生化与分子生物学
最新[2023]版：
大类|3 区生物学
小类|3 区生化与分子生物学
第一作者：
第一作者机构：[1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China,[2]South Sichuan Institute of Translational Medicine, Luzhou, China,
共同第一作者：
通讯作者：
通讯机构：[1]Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China,[2]South Sichuan Institute of Translational Medicine, Luzhou, China,
推荐引用方式(GB/T 7714)：
Shixin Xiang,Yongshun Ma,Jing Shen,et al.m5C RNA Methylation Primarily Affects the ErbB and PI3K-Akt Signaling Pathways in Gastrointestinal Cancer.[J].Frontiers in molecular biosciences.2020,7:599340.doi:10.3389/fmolb.2020.599340.
APA：
Shixin Xiang,Yongshun Ma,Jing Shen,Yueshui Zhao,Xu Wu...&Zhangang Xiao.(2020).m5C RNA Methylation Primarily Affects the ErbB and PI3K-Akt Signaling Pathways in Gastrointestinal Cancer..Frontiers in molecular biosciences,7,
MLA：
Shixin Xiang,et al."m5C RNA Methylation Primarily Affects the ErbB and PI3K-Akt Signaling Pathways in Gastrointestinal Cancer.".Frontiers in molecular biosciences 7.(2020):599340
